Shorter Duration of Trastuzumab Combined With Chemotherapy for Early Breast Cancer

J Clin Oncol. 2024 Sep 1;42(25):3061-3062. doi: 10.1200/JCO.23.02407. Epub 2024 Jun 24.

Authors

Misa Kusumoto¹, Akihiko Shimomura¹, Chikako Shimizu¹

Affiliation

¹ Misa Kusumoto, MD, Akihiko Shimomura, MD, PhD, and Chikako Shimizu, MD, PhD, Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.

PMID: 38913973
DOI: 10.1200/JCO.23.02407

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols* / administration & dosage
Antineoplastic Combined Chemotherapy Protocols* / adverse effects
Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
Breast Neoplasms* / drug therapy
Breast Neoplasms* / pathology
Drug Administration Schedule
Female
Humans
Trastuzumab* / administration & dosage

Substances

Trastuzumab